Cerus to Present at the Cowen and Company34th AnnualHealth Care
Conference, on March 4, 2014
Cowen and Company 34th Annual Healthcare Conference
CONCORD, Calif. -- February 27, 2014
Cerus Corporation (NASDAQ:CERS) announced today that William “Obi” Greenman,
president and chief executive officer, is scheduled to present a corporate
update at the Cowen and Company34^th AnnualHealth Care Conference at 11:20
AM ET on Tuesday, March 4, 2014.
A live webcast of the presentation will be available from the Investor
Relations page of the Cerus web site at http://www.cerus.com/ir. A replay will
be available for approximately two weeks following the completion of the
Cerus Corporation is a biomedical products company focused in the field of
blood safety. Cerus currently markets and sells the INTERCEPT Blood System for
both platelets and plasma in Europe, the Commonwealth of Independent States,
the Middle East and selected countries in other regions around the world. In
the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood
System for plasma and platelets. The INTERCEPT red blood cell system is in
clinical development. See http://www.cerus.com for more information.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.
Lainie Corten, 925-288-6319
Senior Director, Global Marketing & Investor Relations
Press spacebar to pause and continue. Press esc to stop.